Diagnostic News and Research

RSS

A brief questionnaire can help detect autism during toddlerhood

New research led by the University of Cambridge suggests that autism can be detected at 18-30 months using the Quantitative Checklist for Autism in Toddlers (Q-CHAT), but it is not possible to identify every child at a young age who will later be diagnosed as autistic.

16 Jul 2021

MIT engineers create new diagnostic nanoparticle that can pinpoint tumor location

Most of the tests that doctors use to diagnose cancer -- such as mammography, colonoscopy, and CT scans -- are based on imaging. More recently, researchers have also developed molecular diagnostics that can detect specific cancer-associated molecules that circulate in bodily fluids like blood or urine.

16 Jul 2021

Researchers identify a new, promising biomarker for bacterial soft tissue infections

Rapid diagnosis is crucial in bacterial soft tissue infections to reduce the risk of severe injury or amputation.

15 Jul 2021

Imaging technology may be able to treat life-threatening blood clotting condition

Penn State College of Engineering researchers set out to develop technology capable of localizing and imaging blood clots in deep veins. Turns out their work may not only identify blood clots, but it may also be able to treat them.

15 Jul 2021

Rapid COVID-19 antibody detection with time‐resolved fluorescence immunoassay

A new study published in the journal Biotechnology and Applied Biochemistry deals with the development of a time-resolved fluorescence immunoassay (TRFIA) for the detection of total COVID-19 antibodies in humans.

15 Jul 2021

Should we be concerned about the SARS-CoV-2 Lambda variant?

As the coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), wreaks havoc across the globe, the efficacy of available vaccines is being threatened by emerging variants.

15 Jul 2021

A pencil graphite biosensor that detects SARS-CoV-2

In a new study, scientists discuss the development of a rapid COVID-19 diagnostic tool known as the Low-cost Electrochemical Advanced Diagnostic (LEAD).

14 Jul 2021

Nanopore technology allows point-of-care SARS-CoV-2 genomic sequencing

As the SARS-CoV-2 continues to spread worldwide and cause disease and death on a devastating scale, genomic sequencing has become a primary method of keeping track of emerging variants and new outbreaks. A new medRxiv* preprint explores the role of nanopore sequencing in this effort.

14 Jul 2021

Curia to Acquire US-based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics

Curia today announced it has entered into a definitive agreement to acquire LakePharma Inc.

From Curia 14 Jul 2021

Predictive model using vocal features from phone conversations can identify early signs of Alzheimer’s disease

Study shows that a machine learning-based predictive model can be trained using telephone conversations to identify early signs of Alzheimer’s disease.

14 Jul 2021

Metabolomics: The Individual Metabolic Profile is the Key to Personalized Medicine

The study of these unique substances in each of us paves the way for a revolution in the treatment and prevention of diseases, allowing for early diagnosis and increasingly targeted pharmacological treatments.

From Bruker BioSpin Group 14 Jul 2021

Study identifies SARS-CoV-2 spike conformation exposing potential new therapeutic targets

Researchers in the United States have demonstrated that the viral spike protein used by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to infect host cells adopts an open conformation exposing novel epitopes that could serve as targets for therapeutic strategies to protect against coronavirus disease 2019 (COVID-19).

14 Jul 2021

Patient characteristics including demographic factors and comorbidities can accurately predict the outcome of COVID-19 infection severity

New machine learning models incorporating COVID-19 infection data show that patient demography is a key predictor of infection outcome.

13 Jul 2021

Untargeted metabolomics profiling can improve diagnosis of metabolic disorders in newborns

A team led by researchers at Baylor College of Medicine found that a screening method known as untargeted metabolomics profiling can improve the diagnostic rate for inborn errors of metabolism, a group of rare genetic conditions, by about seven-fold when compared to the traditional metabolic screening approach.

12 Jul 2021

Millions of COVID-19 cases went undetected in the first six months of the pandemic, finds study

A new report published in the journal Science Translational Medicine estimates that potentially 16.8 million Americans were infected but not officially diagnosed with SARS-CoV-2 by July 2020. In addition, the results suggest there were nearly five undetected coronavirus cases for every diagnosed coronavirus infection in the first six months of the pandemic.

12 Jul 2021

Immersion in virtual reality can be used to alleviate the discomfort of medical procedures

Pain relief typically involves anesthetic but VR also provides a new technology to limit some of the pain experienced in medical procedures.

12 Jul 2021

Heart attack hospitalization rates rise in England despite decades of decline

The burden of hospital admission rates due to heart attacks in England rose between 2012 and 2016, despite decades of falling rates, suggests new research published in the Journal of Epidemiology & Community Health.

12 Jul 2021

Accelerating the design of minibinder therapeutics resilient to SARS-CoV-2 mutations

Multivalent protein-based minibinders hold great promise as potential prophylactic and treatment agents, as they can retain their activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern. This was revealed in a recent tour-de-force research study currently available on the bioRxiv* preprint server while the article undergoes the peer review process.

11 Jul 2021

Antigen testing identifies PCR-positive children with live SARS-CoV-2

A recent study finds that antigen-based testing can reliably identify children who are infectious for SARS-CoV-2.

11 Jul 2021

New Brigham–Wyss Diagnostic Accelerator could enable fast creation of diagnostic technologies

Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Boston's Brigham and Women Hospital (Brigham) announce their newly founded Diagnostic Accelerator (Brigham-Wyss DxA).

9 Jul 2021

Diagnostic News and Research

A brief questionnaire can help detect autism during toddlerhood

MIT engineers create new diagnostic nanoparticle that can pinpoint tumor location

Researchers identify a new, promising biomarker for bacterial soft tissue infections

Imaging technology may be able to treat life-threatening blood clotting condition

Rapid COVID-19 antibody detection with time‐resolved fluorescence immunoassay

Should we be concerned about the SARS-CoV-2 Lambda variant?

A pencil graphite biosensor that detects SARS-CoV-2

Nanopore technology allows point-of-care SARS-CoV-2 genomic sequencing

Curia to Acquire US-based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics

Predictive model using vocal features from phone conversations can identify early signs of Alzheimer’s disease

Metabolomics: The Individual Metabolic Profile is the Key to Personalized Medicine

Study identifies SARS-CoV-2 spike conformation exposing potential new therapeutic targets

Patient characteristics including demographic factors and comorbidities can accurately predict the outcome of COVID-19 infection severity

Untargeted metabolomics profiling can improve diagnosis of metabolic disorders in newborns

Millions of COVID-19 cases went undetected in the first six months of the pandemic, finds study

Immersion in virtual reality can be used to alleviate the discomfort of medical procedures

Heart attack hospitalization rates rise in England despite decades of decline

Accelerating the design of minibinder therapeutics resilient to SARS-CoV-2 mutations

Antigen testing identifies PCR-positive children with live SARS-CoV-2

New Brigham–Wyss Diagnostic Accelerator could enable fast creation of diagnostic technologies

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News